MUDr. Jozef Ficik, PhD., MPH

Where to find me
Department of Laboratory Medicine
Námestie A. Hlinku 48
034 01 Ružomberok
Office: 304
Phone:
+421 44 438 2730, +421 908 303 356
Email: jozef.ficik@ku.sk
Consulting hours
| Tuesday | 10:00 - 11:00 |
| Wednesday | 10:30 - 11:30 |
Počas konzultačných hodín som k dispozícii na Ústave klinickej mikrobiológie ÚVN SNP - FN v Ružomberku
Professional characteristics
Education
2007 - 2013 LF UPJŠ in Košice, doctor of general medicine
2014 - 2018 SZU in Bratislava, specialization study in the field of clinical microbiology
2019 - 2022 SZU in Bratislava, specialization study MPH (Master of Public Health)
2022 - 2025 LF UK in Bratislava, external PhD studies in the field of medical microbiology and immunology (Ph.D.)
Work experience
2013 - 2014 DONsP in Dolny Kubín, doctor at the neurological department
2014 - 2017 KNsP in Čadca, doctor at the department of clinical microbiology
2018 - 2021 Alpha medical (Unilabs Slovensko), doctor in the laboratory of clinical microbiology,
2019 - 2021 Alpha medical (Unilabs Slovensko), expert representative in the field of clinical microbiology and head of the clinical microbiology laboratory, medical expert for Unilabs in the field of clinical microbiology for the Slovak Republic
2021 - present ÚVN SNP - FN in Ružomberok, Head at the Department of Clinical Microbiology
Publications
PUBLICATIONS IN INTERNATIONAL PEER-REVIEWED INDEXED JOURNALS (WITH IMPACT FACTOR)
-
Ficik, J.; Andrezál, M.; Drahovská, H.; Böhmer, M.; Szemes, T.; Liptáková, A.; Slobodníková, L. Carbapenem-Resistant Klebsiella pneumoniae in COVID-19 Era—Challenges and Solutions. Antibiotics 2023, 12, 1285. DOI: 10.3390/antibiotics12081285
-
Kuzma, J., Zavala-Meneses, S.G., Skultety, L., Chmelar, D., Ficík, J. and Palcová, L. (2023), Antibiotic resistance and biofilm-forming ability of α-toxin-positive Clostridium septicum isolates worsen patient prognosis. APMIS, 131: 434-441. DOI: 10.1111/apm.13338
-
Ficik, J. Toxoplasmosis – seroprevalence and trends over 10 years. Epidemiol Mikrobiol Imunol, 2025; 74(1): 11–19. DOI: 10.61568/emi/11-6445/20250128/139683
SCIENTIFIC PAPERS IN DOMESTIC PEER-REVIEWED JOURNALS (NON-IMPACTED)
-
FICIK, J. et al. Covid and carbapenem-resistant Klebsiella pneumoniae in the hospital environment. In: Health Studies (Zdravotnícke štúdie) [online]. Ružomberok: VERBUM – Catholic University in Ružomberok, 2023, 15 (2), pp. 13-22. ISSN 1337-723X.
-
FICIK, J. A clinical microbiologist's perspective on COVID-19 (up-date). Health Studies (Zdravotnícke štúdie), Vol. XIII, 2/2021, VERBUM – Catholic University in Ružomberok, ISSN 1337-723X.
-
FICIK, J., LIŠČÁKOVÁ, J. Prevalence and antibiotic sensitivity of Ureaplasma urealyticum and Mycoplasma hominis isolated from genital and urinary samples examined between 2014–2017 at KNsP Čadca. 2018, Medirex Group Academy, n.o. ISSN 2454-0021.
PROFESSIONAL ARTICLES IN NON-PEER-REVIEWED JOURNALS AND PROCEEDINGS
-
FICIK, J. Covid-19, monkeypox, multi-resistant bacteria: what's next? inVitro 1/2023.
-
FICIK, J. Secret tools of parasites for human survival. inVitro 2/2022.
-
FICIK, J. The influence of gut microbiota on the development of the nervous system. inVitro 1/2022.
-
FICIK, J. Microorganisms and body weight – the impact of gut microbiota on the development of obesity. inVitro 1/2021.
-
FICIK, J. A clinical microbiologist's perspective on COVID-19. inVitro 2/2020.
